195 related articles for article (PubMed ID: 17522718)
1. CRP has little incremental value over traditional cardiovascular risk factors in risk stratification.
Farkouh ME; Bansilal S; Mathew V
Nat Clin Pract Cardiovasc Med; 2007 Jun; 4(6):290-1. PubMed ID: 17522718
[No Abstract] [Full Text] [Related]
2. The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.
Kones R
Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):309-15. PubMed ID: 19460829
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein, stroke, and statins.
Angerio AD; Bialko MF; White BM
Crit Care Nurs Q; 2007; 30(2):161-5. PubMed ID: 17356357
[TBL] [Abstract][Full Text] [Related]
4. [Inflammation and C-reactive protein in cardiovascular disease].
Munk PS; Larsen AI
Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
[TBL] [Abstract][Full Text] [Related]
5. [CRP level as risk marker of cardiovascular disease?].
Thelle DS; Arnesen E
Tidsskr Nor Laegeforen; 2010 Mar; 130(5):512-4. PubMed ID: 20224622
[No Abstract] [Full Text] [Related]
6. The predictive value of C-reactive protein in end-stage renal disease: is it clinically significant?
van der Sande FM; Kooman JP; Leunissen KM
Blood Purif; 2006; 24(4):335-41. PubMed ID: 16557022
[TBL] [Abstract][Full Text] [Related]
7. The biology, utilization, and attenuation of C-reactive protein in cardiovascular disease: part II.
Armani A; Becker RC
Am Heart J; 2005 Jun; 149(6):977-83. PubMed ID: 15976778
[No Abstract] [Full Text] [Related]
8. Utility of C-reactive protein for cardiovascular risk stratification across three age groups in subjects without existing cardiovascular diseases.
Hamer M; Chida Y; Stamatakis E
Am J Cardiol; 2009 Aug; 104(4):538-42. PubMed ID: 19660608
[TBL] [Abstract][Full Text] [Related]
9. JUPITER study highlights value of anti-inflammatory action of rosuvastatin.
Cardiovasc J Afr; 2009; 20(3):211. PubMed ID: 19575096
[No Abstract] [Full Text] [Related]
10. Should we measure CRP levels to assess cardiovascular risk?
Hadley RD; Graber MA
JAAPA; 2003 Jan; 16(1):17-9. PubMed ID: 12635434
[No Abstract] [Full Text] [Related]
11. The JUPITER trial: How will it change clinical practice?
Watson KE
Rev Cardiovasc Med; 2009; 10(2):91-6. PubMed ID: 19593321
[TBL] [Abstract][Full Text] [Related]
12. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.
Guijarro C
Circulation; 2001 Nov; 104(22):E127. PubMed ID: 11723039
[No Abstract] [Full Text] [Related]
13. High-sensitivity C-reactive protein in every chart? The use of biomarkers in individual patients.
Ben-Yehuda O
J Am Coll Cardiol; 2007 May; 49(21):2139-41. PubMed ID: 17531664
[TBL] [Abstract][Full Text] [Related]
14. Novel cardiac markers.
Alder R
Adv Nurse Pract; 2009 Jun; 17(6):24-7; quiz 28. PubMed ID: 20000180
[No Abstract] [Full Text] [Related]
15. Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?
Nordestgaard BG; Zacho J
Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):521-4. PubMed ID: 19695857
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive assessment of cardiovascular risk: from Framingham to the future.
Vogel RA; Benitez RM
Rev Cardiovasc Med; 2000; 1(1):34-42. PubMed ID: 12457150
[TBL] [Abstract][Full Text] [Related]
17. Predicting benefit from statins by C-reactive protein, LDL-cholesterol or absolute cardiovascular risk.
Stewart RA
Future Cardiol; 2009 May; 5(3):231-6. PubMed ID: 19656039
[TBL] [Abstract][Full Text] [Related]
18. Multiple biomarkers for predicting cardiovascular events: lessons learned.
Wang TJ
J Am Coll Cardiol; 2010 May; 55(19):2092-5. PubMed ID: 20447531
[No Abstract] [Full Text] [Related]
19. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
[TBL] [Abstract][Full Text] [Related]
20. JUPITER study highlights C-reactive protein as a cardiac risk factor.
Cardiovasc J Afr; 2009; 20(2):146. PubMed ID: 19421655
[No Abstract] [Full Text] [Related]
[Next] [New Search]
